Physician profile
Christopher E Justus
NPI 1215943212
$246.70
in general payments reported to CMS, 2019-2025
11 companies · $14.81 in 2025
The $14.81 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.54 · 2022: $27.17 · 2023: $18.20 · 2024: $89.98 · 2025: $14.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $63.82 | 2023-2024 | Andexxa |
| Depuy Synthes Sales INC. | $44.36 | 2024 | Synthecel |
| Nuvasive, INC. | $22.72 | 2021 | |
| Si-Bone, INC. | $18.35 | 2021 | |
| Ibsa Pharma INC. | $18.24 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.07 | 2022 | |
| Smith+Nephew, INC. | $14.81 | 2025 | "Acticoat 4"" X 4""", Pico 7, Pico 14 |
| Scilex Pharmaceuticals INC. | $13.44 | 2021 | |
| Integra Lifesciences Corporation | $12.73 | 2021 | |
| Ethicon US, LLC | $12.10 | 2022 | |
| Biodelivery Sciences International, INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Justus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.